References
- Stein P, Badminton M, Barth J, et al. Best practice guidelines on clinical management of acute attacks of porphyria and their complications. Ann Clin Biochem. 2013;50(Pt 3):217–223.
- Tenhunen R, Tokola O, Lindén IB. Haem arginate: a new stable haem compound. J Pharm Pharmacol. 1987;39(10):780–786.
- Normosang® – summary of product characteristics, labelling and package leaflet. Recordati Rare Diseases Ltd; 2019; [cited 2020, Oct 18]. Available from: https://www.recordatirarediseases.com/sites/www.recordatirarediseases.com/files/inline-files/NOR_SmPC.pdf
- Frei P, Minder EI, Corti N, et al. Liver transplantation because of acute liver failure due to heme arginate overdose in a patient with acute intermittent porphyria. Case Rep Gastroenterol. 2012;6(1):190–196.